Delivery Order SPE2DR25D2022-SPE2DR26F2ZMK
- Not listed
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is for the delivery of DAPTACEL DTAP vaccine in 0.5mL doses. The $1,159.16 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical division and has a completion date of February 12, 2024. Amerisourcebergen Drug Corp, located in Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which does not...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of DAPTACEL DTAP vaccine with a potential value of $1,536.16. The contract has a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and has received numerous prior delivery orders from DLA to provide pharmaceuticals, medical supplies, and related distribution...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Daptacel DTaP vaccine in 0.5 ml doses. The firm-fixed-price delivery order, valued at $1,548.80, has a completion date of February 13, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DAPTACEL DTAP vaccine in 0.5 ml doses, with a ceiling value of $1,603.90 and a completion date of May 29, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the for-profit pharmaceutical distribution company Amerisourcebergen Corporation. The $1,548.80 firm fixed price contract provides the DAPTACEL PF VACC 10S vaccine product to support military treatment programs. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a...
- The Defense Logistics Agency awarded a $1,913.65 delivery order to AmerisourceBergen Drug Corp for INFANRIX DTAP vaccine syringes (0.5mL) with a completion date of August 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the DAPTACEL DTAP vaccine in 0.5 mL doses. The contract has a firm fixed price of $1,603.90 and a performance period through June 11, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,430.70 for INFANRIX DTAP syringe 0.5ML, a standard diphtheria, tetanus, and acellular pertussis vaccine product. The award was made on November 26, 2025, with an ultimate completion date of November 28, 2025, under a firm fixed-price delivery order contract type with no set-aside designation. The contract will be performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order...
- This federal contract award, valued at $1,548.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the DAPTACEL DTAP vaccine in 0.5 ml quantities, with a completion date of May 9, 2024. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. As a major supplier of pharmaceutical products and medical supplies...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,697.36 firm-fixed-price delivery order is for the supply of DAPTACEL DTAP VACCINE 0.5ML, with an ultimate completion date of February 8, 2022. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier...
- SPE2DR25D2022Indefinite Delivery Contract
- SPE2DR25D2022-SPE2DR26F2ZMKDelivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $1,178.09 to AmerisourceBergen Drug Corp for the supply of Daptacel DTAP Vaccine in 0.5ml doses. The contract was competitively awarded without a set-aside designation and is scheduled for completion by December 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply vaccines, medications, and medical supplies to support military healthcare programs worldwide. The Daptacel vaccine delivery supports the Defense Health Agency and other federal healthcare systems' immunization requirements across the military health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/22/25 |